Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Jul 13.
Published in final edited form as: Pediatr Res. 2016 Aug;80(2):326. doi: 10.1038/pr.2016.109

Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23–29 wk

PMCID: PMC5508872  NIHMSID: NIHMS872518  PMID: 27537417

Dale L Phelps, Robert M. Ward, Rick L. Williams, Kristi L. Watterberg, Abbott R. Laptook, Lisa A. Wrage, Tracy L. Nolen, Timothy R. Fennell, Richard A. Ehrenkranz, Brenda B. Poindexter, C. Michael Cotten, Mikko K. Hallman, Ivan D. Frantz III, Roger G. Faix, Kristin M. Zaterka-Baxter, Abhik Das, M. Bethany Ball, T. Michael O’Shea, Conra Backstrom Lacy, Michele C. Walsh, Seetha Shankaran, Pablo J. Sánchez, Edward F. Bell, Rosemary D. Higgins for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.

Pediatr Res 74:721–729 (2013); doi:10.1038/pr.2013.162

As a result of an authors’ error, an incorrect version of Figure 4 was published in the original manuscript illustrating the predicted serum concentrations of inositol for a repeated 160mg/kg daily dose, rather than the intended 80mg/kg/daily dose. The published legend for the figure, and manuscript text, describe the intended figure. The authors regret this error and apologize for any inconvenience.

Figure 4 (corrected)

Figure 4.

Figure 4

The model described in the PK section (before covariates) was used to predict the pattern of serum levels for a typical infant given repeated doses of 80 mg/kg/day divided into 40 mg/kg every 12 h for 36 h.

RESOURCES